Clinical Trial Update: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Pfizer completed a post-marketing drug-use investigation of intravenous azithromycin for pneumonia and pelvic inflammatory disease, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Inflammatory Disease
• Pneumonia

Drugs mentioned

• Azithromycin IV (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Pelvic Inflammatory Disease | Status: COMPLETED | Results posted: 2017-04-26